Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Clinical trial NCT01431794 · TERMINATED
Trial details
- NCT number
- NCT01431794
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-27
- Primary completion
- 2018-11-05
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.